COVID-19 Vaccine Maker Starts Working on Shots, Health News, ET Health World for Omicron

BioNTech, Moderna, Johnson & Johnson are working on vaccines specifically targeted Omicron The two companies said Monday in case their existing shots weren’t effective against the new coronavirus variant.

The emergence of this variant has sparked a strong global response, as countries are concerned that vaccinated populations may also spread rapidly. Travel curb And other restrictions.

BioNTech SE said it has begun developing a vaccine tailored to Omicron with partner Pfizer.

Meanwhile, Moderna Inc could take months to begin shipping such vaccines, CEO Stephane Bancel told CNBC.

Bansel stated the existing effectiveness COVID-19 (new coronavirus infection) Vaccines against mutants are currently unknown and should become clearer in about two weeks.

While Johnson & Johnson are also assessing the efficacy of the COVID-19 vaccine against Omicron, they are also pursuing vaccines that are specific to that variant.

Matthew Mamen, Head of Global Research at J & J’s Pharmaceuticals Division, said:

Top South African infectious disease experts said Omicron appears to be more contagious than previous variants. Immunity From vaccination or previous infection.

(Report by Manas Mishra in Bangalore; edited by Sriraj Kalluvila)

Back to top button